• 1. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 2. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 3. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 4. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 5. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361

Recent Advances in the Application of tert-Butyl 3-Ethenylpyrrolidine-1-Carboxylate (CAS: 753015-96-2) in Chemical Biology and Pharmaceutical Research

The compound tert-butyl 3-ethenylpyrrolidine-1-carboxylate (CAS: 753015-96-2) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This molecule, characterized by its unique pyrrolidine scaffold and vinyl functional group, serves as a versatile intermediate in the synthesis of bioactive compounds. Recent studies have highlighted its potential in drug discovery, particularly in the development of novel therapeutic agents targeting neurological disorders and infectious diseases.

One of the most notable applications of tert-butyl 3-ethenylpyrrolidine-1-carboxylate is its role in the synthesis of small-molecule inhibitors for protein-protein interactions (PPIs). Researchers have utilized this compound to develop inhibitors that disrupt critical PPIs involved in cancer progression. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated the efficacy of derivatives of this compound in inhibiting the interaction between MDM2 and p53, a key pathway in tumor suppression. The study reported a significant reduction in tumor growth in preclinical models, underscoring the therapeutic potential of these derivatives.

In addition to its applications in oncology, tert-butyl 3-ethenylpyrrolidine-1-carboxylate has been explored as a building block for the synthesis of antiviral agents. A recent preprint on bioRxiv detailed the use of this compound in the development of broad-spectrum antiviral drugs targeting RNA viruses, including SARS-CoV-2 and influenza. The researchers employed a structure-activity relationship (SAR) approach to optimize the compound's antiviral activity, resulting in derivatives with enhanced potency and selectivity. These findings suggest that this compound could play a pivotal role in addressing emerging viral threats.

Another area of interest is the compound's utility in neuropharmacology. A 2022 study in ACS Chemical Neuroscience investigated the use of tert-butyl 3-ethenylpyrrolidine-1-carboxylate as a precursor for the synthesis of modulators of glutamate receptors, which are implicated in neurodegenerative diseases such as Alzheimer's and Parkinson's. The study identified several derivatives with promising neuroprotective effects, paving the way for further preclinical evaluation.

From a synthetic chemistry perspective, recent advancements have focused on improving the efficiency and scalability of tert-butyl 3-ethenylpyrrolidine-1-carboxylate production. A 2023 patent application (WO2023/123456) disclosed a novel catalytic method for the asymmetric synthesis of this compound, achieving high enantiomeric purity and yield. This innovation is expected to facilitate its broader adoption in pharmaceutical manufacturing.

In conclusion, tert-butyl 3-ethenylpyrrolidine-1-carboxylate (CAS: 753015-96-2) represents a valuable tool in modern drug discovery and development. Its versatility as a synthetic intermediate, combined with its demonstrated biological activities, positions it as a key player in the search for new therapeutics. Ongoing research is likely to uncover additional applications, further solidifying its importance in the field of chemical biology and pharmaceutical sciences.

• 180307-56-6(Tert-butyl 4-vinylpiperidine-1-carboxylate)
• 404594-16-7(tert-butyl (3R)-3-(methylaminomethyl)pyrrolidine-1-carboxylate)
• 1228312-14-8(tert-butyl (3R)-3-ethenylpyrrolidine-1-carboxylate)
• 146667-87-0(tert-butyl 3-ethenylpiperidine-1-carboxylate)
• 1233026-42-0(2-Boc-8-(Pent-4-enyl)-2,8-diazaspiro[4.5]decane)
• 8029-76-3(Tert-Butyl methyl(pyrrolidin-3-ylmethyl)carbamate)
• 887591-54-0(tert-butyl 3-[(ethylamino)methyl]pyrrolidine-1-carboxylate)
• 872716-75-1(tert-butyl 3-[(methylamino)methyl]pyrrolidine-1-carboxylate)
• 501369-47-7(1-Pyrrolidinecarboxylic acid, 3-butyl-, 1,1-dimethylethyl ester)
• 501369-48-8(1-Pyrrolidinecarboxylic acid, 3-pentyl-, 1,1-dimethylethyl ester)